Lexicon Pharmaceuticals, INC. (LXRX) — DEF 14A Filings
All DEF 14A filings from Lexicon Pharmaceuticals, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Lexicon Pharma Details 2024 Executive Compensation
— Apr 22, 2025 Risk: medium
Lexicon Pharmaceuticals, Inc. filed a DEF 14A on April 22, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing inclu -
Lexicon Pharmaceuticals Announces 2024 Annual Meeting of Stockholders
— Mar 26, 2024 Risk: low
LEXICON PHARMACEUTICALS, INC. (LXRX) filed a Proxy Statement (DEF 14A) with the SEC on March 26, 2024. The 2024 annual meeting of Lexicon Pharmaceuticals, Inc.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX